Table 3 Anthropometric and body composition measures by group and visit
YY-312 group | Placebo group | P-value* | |||
|---|---|---|---|---|---|
n | Mean ± SD | n | Mean ± SD | ||
Weight (kg) | |||||
Baseline | 30 | 75.0 ± 11.0 | 30 | 72.6 ± 10.8 | 0.400 |
6 weeks | 24 | 71.7 ± 10.5 | 26 | 72.2 ± 11.1 | 0.879 |
12 weeks | 20 | 70.6 ± 11.4 | 19 | 69.9 ± 9.1 | 0.834 |
BMI (kg/m2) | |||||
Baseline | 30 | 27.1 ± 1.5 | 30 | 27.2 ± 1.2 | 0.692 |
6 weeks | 24 | 26.2 ± 1.7 | 26 | 27.0 ± 1.3 | 0.097 |
12 weeks | 20 | 25.8 ± 1.9 | 19 | 26.7 ± 1.4 | 0.135 |
WC (cm) | |||||
Baseline | 30 | 88.3 ± 6.5 | 30 | 89.0 ± 7.1 | 0.705 |
6 weeks | 24 | 86.2 ± 5.8 | 26 | 88.5 ± 7.4 | 0.230 |
12 weeks | 20 | 85.6 ± 6.7 | 19 | 87.4 ± 7.4 | 0.434 |
Body Fat (%) | |||||
Baseline | 30 | 32.2 ± 5.5 | 30 | 32.9 ± 4.6 | 0.562 |
12 weeks | 20 | 30.0 ± 5.9 | 19 | 32.4 ± 5.5 | 0.199 |
BFM (kg) | |||||
Baseline | 30 | 22.6 ± 3.8 | 30 | 22.6 ± 3.6 | 0.961 |
12 weeks | 20 | 20.1 ± 4.7 | 19 | 21.4 ± 3.5 | 0.335 |
LBM (kg) | |||||
Baseline | 30 | 48.6 ± 10.0 | 30 | 46.5 ± 8.8 | 0.392 |
12 weeks | 20 | 47.4 ± 9.7 | 19 | 45.4 ± 8.6 | 0.494 |